Volume 4, Issue 1 | January 2026

About  |  Impact Stories   |  Technology Licensing  |  Careers  |   Press  |  Contact

Measure what matters.
Mayo Clinic’s Clinical Outcome Assessment (COA) tools are ready to license to support enhanced care and research.
Learn more
Mayo Clinic biopharma innovation portfolio — now available
Explore a curated innovation portfolio featuring Mayo Clinic–originated companies raising capital and partner-ready technologies available for licensing or collaboration, spanning multiple modalities and disease areas.
See what's inside
Ecosystem spotlight

Building tomorrow’s healthcare with Craig Daniels, M.D. 
Mayo Clinic Magazine

What if healthcare were designed around people, not buildings? Through Bold. Forward. Unbound., Mayo Clinic is reshaping care into connected “neighborhoods” where teams, technology and healing spaces work as one - creating a smoother, more human experience for patients today and generations to come. Read more...

What to expect in pharma manufacturing in 2026: Industry leaders share their predictions
Pharma Source
As pharma manufacturing heads deeper into 2026, the industry is navigating tighter capital, heightened scrutiny and growing pressure to prove value earlier. Mayo Clinic’s Audrey Greenberg underscores how this shift is redefining biotech strategy: investors now expect capital-efficient CMC programs that demonstrate manufacturability, cost trajectory and regulatory readiness from the outset. Read more...
News across the spectrum 

What’s next in AI: 7 trends to watch in 2026 

Bottom line: AI is moving deeper into daily workflows, research and decision-making. Read more...
Phoenix ranks No. 1 large city for startups

Bottom line: A fast-growing talent pool and business-friendly climate are powering Arizona’s rise. Read more...
SciencePower to advance research on postbiotics 

Bottom line: Alongside Mayo Clinic, SciencePower is exploring a promising new frontier in breast cancer biology. Read more...
‘Powered by people’: Mayo Clinic on shaping future of surgery

Bottom line: AI is being applied behind the scenes to improve surgical flow, planning and reliability.
Read more...
Medical innovation in Minnesota fuels national diagnostics strategy

Bottom line: Big players are betting on earlier, easier cancer screening. Read more... 
Research

N of 1: A vision for research at Mayo Clinic 
Mayo Clinic Magazine

Medicine is moving from averages to individuals. Mayo Clinic’s N of 1 approach uses data, AI and digital tools to personalize prevention and treatment - aiming to detect disease earlier, speed discovery and deliver care tailored to each patient, not the population. Read more...
10 Mayo Clinic research breakthroughs from 2025 moving medicine forward
Mayo Clinic News Network

Read more...
Mayo Clinic researchers develop AI-ECG model to diagnose liver disease earlier 
Mayo Clinic News Network

Read more...
Finance

Why top healthcare investors think 2026 will reshape medicine forever 
Forbes

Top healthcare investors predict that AI will shift from experimental to essential, powering everything from clinical decision support and operational automation to real-time evidence generation and AI-native biopharma while payer services, data security and new measurement tools become major investment focuses next year. Read more...
Lin Health raises $11 million Series A
PR Newswire

Read more...
Ultromics secures new investment
PR Newswire

Read more...
Vyriad, Mayo Clinic startup, raises $25M for trial of multiple myeloma treatment
Minneapolis/St. Paul Business Journal 

Vyriad, a Rochester, Minn.–based clinical-stage biotech co-founded by Mayo Clinic clinician-scientists, has closed the final $25 million tranche of its Series B round, bringing total funding to $85 million to advance its in vivo CAR-T therapy candidate (VV169) into first-in-human trials for relapsed or refractory multiple myeloma. Read more...
HEARD AROUND MAYO CLINIC 
WHAT OUR LEADERS ARE TALKING ABOUT

Dr. Bhagra talks about Mayo Clinic’s strategic approach to creating true systemic change utilizing automation. 
As a stem cell biologist, Ming-Fen highlights how miniature models of the human brain are driving new discoveries in psychiatry. 
Dr. Shah discusses some of the key questions at the center of Mayo Clinic’s precision medicine programs.

CONNECT WITH US | UPCOMING EVENTS
Find select Mayo Clinic Business Development staff at:
  • J.P. Morgan Healthcare Conference | Jan. 12-15 | San Francisco, CA
  • AUTM Annual Meeting | Feb. 8-11 | Seattle, WA
  • Advanced Therapies Week | Feb. 9-12 | San Diego, CA 
  • ViVE 2026 | Feb. 22-25 | Los Angeles, CA 
  • Biocom California | Feb. 24-26 | San Diego, CA 
  • RAEDI Annual Meeting | Feb. 26 | Rochester, MN
  • LSI USA | March 16-20 | Dana Point, CA 

MAYO CLINIC BUSINESS DEVELOPMENT | OPEN POSITIONS:
  • Technology Development Associate
  • Senior Licensing Manager
  • Business Development Manager II - Commercialization
Get caught up

View past issues packed with healthcare innovation and business development highlights.
Explore the archives

About Business Development
Business Development is Mayo Clinic’s front door to business – from technology commercialization to strategic collaborations – catalyzing innovation to shape the future of healthcare for the benefit of patients.

The department bridges the gaps between industry and commercial groups to produce meaningful, effective changes in transforming health and medicine.
Subscribe to receive updates directly.
Mayo Clinic 200 First St. SW | Rochester, MN 55905
Copyright 2026 Mayo Foundation for Medical Education and Research. All rights reserved.